Examining Factors Associated with Dynapenia/Sarcopenia in Patients with Schizophrenia: A Pilot Case-Control Study

Sedentary behavior in patients with schizophrenia causes muscle weakness, is associated with a higher risk of metabolic syndrome, and contributes to mortality risk. This pilot case-control study aims to examine the associated factors for dynapenia/sarcopenia in patients with schizophrenia. The parti...

Full description

Saved in:
Bibliographic Details
Published inHealthcare (Basel) Vol. 11; no. 5; p. 684
Main Authors Tanioka, Ryuichi, Osaka, Kyoko, Ito, Hirokazu, Zhao, Yueren, Tomotake, Masahito, Takase, Kensaku, Tanioka, Tetsuya
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 25.02.2023
MDPI
Subjects
Online AccessGet full text
ISSN2227-9032
2227-9032
DOI10.3390/healthcare11050684

Cover

Abstract Sedentary behavior in patients with schizophrenia causes muscle weakness, is associated with a higher risk of metabolic syndrome, and contributes to mortality risk. This pilot case-control study aims to examine the associated factors for dynapenia/sarcopenia in patients with schizophrenia. The participants were 30 healthy individuals (healthy group) and 30 patients with schizophrenia (patient group), who were matched for age and sex. Descriptive statistics, Welch’s t-test, cross-tabulations, adjusted residuals, Fisher’s exact probability test (extended), and/or odds ratios (ORs) were calculated. In this study, dynapenia was significantly more prevalent in patients with schizophrenia than in healthy individuals. Regarding body water, Pearson’s chi-square value was 4.41 (p = 0.04), and significantly more patients with dynapenia were below the normal range. In particular, body water and dynapenia showed a significant association, with an OR = 3.42 and 95% confidence interval [1.06, 11.09]. Notably, compared with participants of the healthy group, patients with schizophrenia were overweight, had less body water, and were at a higher risk for dynapenia. The impedance method and the digital grip dynamometer used in this study were simple and useful tools for evaluating muscle quality. To improve health conditions for patients with schizophrenia, additional attention should be paid to muscle weakness, nutritional status, and physical rehabilitation.
AbstractList Sedentary behavior in patients with schizophrenia causes muscle weakness, is associated with a higher risk of metabolic syndrome, and contributes to mortality risk. This pilot case-control study aims to examine the associated factors for dynapenia/sarcopenia in patients with schizophrenia. The participants were 30 healthy individuals (healthy group) and 30 patients with schizophrenia (patient group), who were matched for age and sex. Descriptive statistics, Welch's -test, cross-tabulations, adjusted residuals, Fisher's exact probability test (extended), and/or odds ratios (ORs) were calculated. In this study, dynapenia was significantly more prevalent in patients with schizophrenia than in healthy individuals. Regarding body water, Pearson's chi-square value was 4.41 ( = 0.04), and significantly more patients with dynapenia were below the normal range. In particular, body water and dynapenia showed a significant association, with an OR = 3.42 and 95% confidence interval [1.06, 11.09]. Notably, compared with participants of the healthy group, patients with schizophrenia were overweight, had less body water, and were at a higher risk for dynapenia. The impedance method and the digital grip dynamometer used in this study were simple and useful tools for evaluating muscle quality. To improve health conditions for patients with schizophrenia, additional attention should be paid to muscle weakness, nutritional status, and physical rehabilitation.
Sedentary behavior in patients with schizophrenia causes muscle weakness, is associated with a higher risk of metabolic syndrome, and contributes to mortality risk. This pilot case-control study aims to examine the associated factors for dynapenia/sarcopenia in patients with schizophrenia. The participants were 30 healthy individuals (healthy group) and 30 patients with schizophrenia (patient group), who were matched for age and sex. Descriptive statistics, Welch’s t -test, cross-tabulations, adjusted residuals, Fisher’s exact probability test (extended), and/or odds ratios (ORs) were calculated. In this study, dynapenia was significantly more prevalent in patients with schizophrenia than in healthy individuals. Regarding body water, Pearson’s chi-square value was 4.41 ( p = 0.04), and significantly more patients with dynapenia were below the normal range. In particular, body water and dynapenia showed a significant association, with an OR = 3.42 and 95% confidence interval [1.06, 11.09]. Notably, compared with participants of the healthy group, patients with schizophrenia were overweight, had less body water, and were at a higher risk for dynapenia. The impedance method and the digital grip dynamometer used in this study were simple and useful tools for evaluating muscle quality. To improve health conditions for patients with schizophrenia, additional attention should be paid to muscle weakness, nutritional status, and physical rehabilitation.
Sedentary behavior in patients with schizophrenia causes muscle weakness, is associated with a higher risk of metabolic syndrome, and contributes to mortality risk. This pilot case-control study aims to examine the associated factors for dynapenia/sarcopenia in patients with schizophrenia. The participants were 30 healthy individuals (healthy group) and 30 patients with schizophrenia (patient group), who were matched for age and sex. Descriptive statistics, Welch’s t-test, cross-tabulations, adjusted residuals, Fisher’s exact probability test (extended), and/or odds ratios (ORs) were calculated. In this study, dynapenia was significantly more prevalent in patients with schizophrenia than in healthy individuals. Regarding body water, Pearson’s chi-square value was 4.41 (p = 0.04), and significantly more patients with dynapenia were below the normal range. In particular, body water and dynapenia showed a significant association, with an OR = 3.42 and 95% confidence interval [1.06, 11.09]. Notably, compared with participants of the healthy group, patients with schizophrenia were overweight, had less body water, and were at a higher risk for dynapenia. The impedance method and the digital grip dynamometer used in this study were simple and useful tools for evaluating muscle quality. To improve health conditions for patients with schizophrenia, additional attention should be paid to muscle weakness, nutritional status, and physical rehabilitation.
Sedentary behavior in patients with schizophrenia causes muscle weakness, is associated with a higher risk of metabolic syndrome, and contributes to mortality risk. This pilot case-control study aims to examine the associated factors for dynapenia/sarcopenia in patients with schizophrenia. The participants were 30 healthy individuals (healthy group) and 30 patients with schizophrenia (patient group), who were matched for age and sex. Descriptive statistics, Welch's t-test, cross-tabulations, adjusted residuals, Fisher's exact probability test (extended), and/or odds ratios (ORs) were calculated. In this study, dynapenia was significantly more prevalent in patients with schizophrenia than in healthy individuals. Regarding body water, Pearson's chi-square value was 4.41 (p = 0.04), and significantly more patients with dynapenia were below the normal range. In particular, body water and dynapenia showed a significant association, with an OR = 3.42 and 95% confidence interval [1.06, 11.09]. Notably, compared with participants of the healthy group, patients with schizophrenia were overweight, had less body water, and were at a higher risk for dynapenia. The impedance method and the digital grip dynamometer used in this study were simple and useful tools for evaluating muscle quality. To improve health conditions for patients with schizophrenia, additional attention should be paid to muscle weakness, nutritional status, and physical rehabilitation.Sedentary behavior in patients with schizophrenia causes muscle weakness, is associated with a higher risk of metabolic syndrome, and contributes to mortality risk. This pilot case-control study aims to examine the associated factors for dynapenia/sarcopenia in patients with schizophrenia. The participants were 30 healthy individuals (healthy group) and 30 patients with schizophrenia (patient group), who were matched for age and sex. Descriptive statistics, Welch's t-test, cross-tabulations, adjusted residuals, Fisher's exact probability test (extended), and/or odds ratios (ORs) were calculated. In this study, dynapenia was significantly more prevalent in patients with schizophrenia than in healthy individuals. Regarding body water, Pearson's chi-square value was 4.41 (p = 0.04), and significantly more patients with dynapenia were below the normal range. In particular, body water and dynapenia showed a significant association, with an OR = 3.42 and 95% confidence interval [1.06, 11.09]. Notably, compared with participants of the healthy group, patients with schizophrenia were overweight, had less body water, and were at a higher risk for dynapenia. The impedance method and the digital grip dynamometer used in this study were simple and useful tools for evaluating muscle quality. To improve health conditions for patients with schizophrenia, additional attention should be paid to muscle weakness, nutritional status, and physical rehabilitation.
Audience Academic
Author Zhao, Yueren
Tanioka, Ryuichi
Takase, Kensaku
Tomotake, Masahito
Osaka, Kyoko
Ito, Hirokazu
Tanioka, Tetsuya
AuthorAffiliation 2 Department of Nursing, Nursing Course of Kochi Medical School, Kochi University, Kochi 783-8505, Japan
1 Faculty of Health Sciences, Hiroshima Cosmopolitan University, Hiroshima 731-3166, Japan
3 Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8509, Japan
4 Department of Psychiatry, Fujita Health University, Toyoake 470-1192, Japan
5 Department of Rehabilitation, Anan Medical Center, Anan 774-0045, Japan
AuthorAffiliation_xml – name: 2 Department of Nursing, Nursing Course of Kochi Medical School, Kochi University, Kochi 783-8505, Japan
– name: 3 Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8509, Japan
– name: 1 Faculty of Health Sciences, Hiroshima Cosmopolitan University, Hiroshima 731-3166, Japan
– name: 4 Department of Psychiatry, Fujita Health University, Toyoake 470-1192, Japan
– name: 5 Department of Rehabilitation, Anan Medical Center, Anan 774-0045, Japan
Author_xml – sequence: 1
  givenname: Ryuichi
  surname: Tanioka
  fullname: Tanioka, Ryuichi
– sequence: 2
  givenname: Kyoko
  surname: Osaka
  fullname: Osaka, Kyoko
– sequence: 3
  givenname: Hirokazu
  surname: Ito
  fullname: Ito, Hirokazu
– sequence: 4
  givenname: Yueren
  surname: Zhao
  fullname: Zhao, Yueren
– sequence: 5
  givenname: Masahito
  surname: Tomotake
  fullname: Tomotake, Masahito
– sequence: 6
  givenname: Kensaku
  surname: Takase
  fullname: Takase, Kensaku
– sequence: 7
  givenname: Tetsuya
  orcidid: 0000-0002-2847-1862
  surname: Tanioka
  fullname: Tanioka, Tetsuya
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36900689$$D View this record in MEDLINE/PubMed
BookMark eNp9kl1vFCEUhompsbX2D3hhSLzxZlo-Z8Abs1lbNWlik-09YRlmh2YWtsBUt7--jFtrW41wwQk87wuHc16DPR-8BeAtRseUSnTSWz3k3uhoMUYc1YK9AAeEkKaSiJK9R_E-OErpCpUhMRWUvwL7tJaoSOQBuD79qdfOO7-CZ9rkEBOcpRSM09m28IfLPfy89XpjvdMnCx1N-BVC5-GFzs76nHbUwvTuNmz6OB1_hDN44YaQ4VwnW82DzzEMcJHHdvsGvOz0kOzR_XoILs9OL-dfq_PvX77NZ-eV4YzkChO67FqBGSO6s1ygJa1rJjQ3jGFDOtbJZcOwtajTlFImeS1EI3GDWiERpofg0852My7XtjXlpVEPahPdWsetCtqppyfe9WoVbhSefopzXhw-3DvEcD3alNXaJWOHQXsbxqRII2okhaSsoO-foVdhjL6kN1Eci4Yz_Ida6cEq57tQLjaTqZqVVASrUY0KdfwPqszWrp0pTdC5sv9E8O5xpg8p_i5yAcgOMDGkFG33gGCkpmZSfzdTEYlnIuNyqfhUSu2G_0nvAI3y0Iw
CitedBy_id crossref_primary_10_3390_healthcare13010048
crossref_primary_10_3390_healthcare13060604
Cites_doi 10.1016/j.schres.2010.02.1061
10.1016/S2215-0366(17)30079-2
10.1016/j.exger.2013.02.012
10.1186/1744-859X-11-11
10.1016/j.orcp.2014.08.003
10.1016/j.schres.2006.05.013
10.3389/fpsyt.2014.00137
10.1016/j.clnu.2017.01.005
10.20944/preprints201706.0081.v1
10.1007/s00406-013-0436-x
10.1093/ageing/afy169
10.1159/000485729
10.1249/00003677-199301000-00003
10.1016/j.schres.2010.10.025
10.1111/acps.12445
10.1002/wps.20647
10.1007/s12603-013-0362-7
10.1016/S2215-0366(15)00115-7
10.1016/j.clnu.2014.03.007
10.1097/MCO.0b013e328337819e
10.22540/JFSF-03-194
10.1136/bmjopen-2015-008720
10.3389/fphys.2012.00260
10.3389/fmed.2021.755705
10.5152/pcp.2021.20175
10.1002/jcsm.12651
10.1016/j.scog.2014.06.002
10.1016/j.mhpa.2020.100364
10.1002/wps.20458
10.1186/s40798-022-00490-3
10.5694/j.1326-5377.1976.tb128209.x
10.3390/healthcare10101905
10.1016/j.schres.2011.03.018
10.3389/fpsyg.2020.525231
10.2152/jmi.69.70
10.1038/s41598-020-76185-0
10.1016/j.jamda.2013.05.021
10.1016/j.jamda.2019.12.012
10.1016/j.ejrad.2016.03.001
10.1111/jdi.12908
10.1002/j.2051-5545.2009.tb00199.x
10.1016/j.schres.2017.10.017
ContentType Journal Article
Copyright COPYRIGHT 2023 MDPI AG
2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2023 by the authors. 2023
Copyright_xml – notice: COPYRIGHT 2023 MDPI AG
– notice: 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2023 by the authors. 2023
DBID AAYXX
CITATION
NPM
3V.
7RV
7XB
8C1
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
KB0
M2O
MBDVC
NAPCQ
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOI 10.3390/healthcare11050684
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
ProQuest Central (purchase pre-March 2016)
ProQuest Public Health Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
Nursing & Allied Health Database (Alumni Edition)
Research Library
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Central China
ProQuest Central
Health Research Premium Collection
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Public Health
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList PubMed

CrossRef
Publicly Available Content Database
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 2227-9032
ExternalDocumentID PMC10000555
A741846060
36900689
10_3390_healthcare11050684
Genre Journal Article
GeographicLocations Japan
GeographicLocations_xml – name: Japan
GrantInformation_xml – fundername: Grant-in-Aid for Scientific Research
  grantid: JP17H01609
– fundername: Japan Society for the Promotion of Science
  grantid: JP17H01609
– fundername: Center for Design-based AI Education and Research, University of Tokushima
GroupedDBID 53G
5VS
7RV
8C1
8FI
8FJ
8G5
AAFWJ
AAHBH
AAYXX
ABUWG
ADBBV
AFKRA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BPHCQ
CCPQU
CITATION
DIK
DWQXO
EIHBH
FYUFA
GNUQQ
GUQSH
GX1
HYE
IAO
IHR
ITC
KQ8
M2O
M48
MODMG
M~E
NAPCQ
OK1
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
RNS
RPM
UKHRP
3V.
GROUPED_DOAJ
NPM
PMFND
7XB
8FK
MBDVC
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
Q9U
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c542t-123bfd81442afe580b36648a5c441c2f4f9b741ee0fa33349568879170d89013
IEDL.DBID M48
ISSN 2227-9032
IngestDate Thu Aug 21 18:37:44 EDT 2025
Fri Sep 05 11:50:54 EDT 2025
Sat Jul 26 00:02:38 EDT 2025
Fri May 23 01:41:50 EDT 2025
Tue Jun 10 21:14:57 EDT 2025
Thu Jan 02 22:52:18 EST 2025
Thu Apr 24 23:11:48 EDT 2025
Tue Jul 01 04:06:09 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords body mass index
basal metabolic rate
schizophrenia
total muscle mass
skeletal muscle mass
dynapenia
sarcopenia
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c542t-123bfd81442afe580b36648a5c441c2f4f9b741ee0fa33349568879170d89013
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-2847-1862
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/healthcare11050684
PMID 36900689
PQID 2785187541
PQPubID 2032390
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_10000555
proquest_miscellaneous_2786098934
proquest_journals_2785187541
gale_infotracmisc_A741846060
gale_infotracacademiconefile_A741846060
pubmed_primary_36900689
crossref_primary_10_3390_healthcare11050684
crossref_citationtrail_10_3390_healthcare11050684
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20230225
PublicationDateYYYYMMDD 2023-02-25
PublicationDate_xml – month: 2
  year: 2023
  text: 20230225
  day: 25
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Healthcare (Basel)
PublicationTitleAlternate Healthcare (Basel)
PublicationYear 2023
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Tanioka (ref_49) 2022; 69
Schreurs (ref_4) 2009; 8
Chen (ref_21) 2020; 21
Sugai (ref_17) 2015; 5
Okumura (ref_43) 2010; 119
Rogers (ref_39) 1993; 21
Galletly (ref_3) 2017; 4
ref_19
ref_18
Gao (ref_16) 2021; 8
Vellas (ref_20) 2013; 17
Kurose (ref_35) 2020; 10
Marthoenis (ref_24) 2022; 2022
Zhou (ref_25) 2018; 40
(ref_29) 2020; 11
Ringen (ref_2) 2014; 5
Bulbul (ref_27) 2021; 31
ref_23
Verlaan (ref_45) 2018; 37
Strassnig (ref_11) 2011; 126
Harvey (ref_33) 2019; 18
ref_28
Vancampfort (ref_9) 2017; 16
Fukuoka (ref_42) 2019; 10
Santilli (ref_38) 2014; 11
Henderson (ref_7) 2015; 2
Neves (ref_31) 2018; 3
Erlandson (ref_22) 2016; 85
Nilwik (ref_36) 2013; 48
Bahat (ref_14) 2019; 48
Sugawara (ref_47) 2018; 195
Chang (ref_41) 2015; 9
Hara (ref_46) 2018; 196
Biolo (ref_32) 2014; 33
Strassnig (ref_13) 2006; 86
Bauer (ref_44) 2013; 14
Kitamura (ref_40) 2021; 12
Schoepf (ref_12) 2014; 264
Strassnig (ref_5) 2014; 1
Manu (ref_10) 2015; 132
Mitchell (ref_37) 2012; 3
Brobakken (ref_48) 2022; 8
ref_1
Kobayashi (ref_30) 2020; 82
Sugawara (ref_6) 2012; 11
Vancampfort (ref_8) 2011; 129
Hankin (ref_26) 1976; 2
Clark (ref_15) 2010; 13
Strassnig (ref_34) 2021; 20
References_xml – volume: 119
  start-page: 145
  year: 2010
  ident: ref_43
  article-title: Prevalence of diabetes and antipsychotic prescription patterns in patients with schizophrenia: A nationwide retrospective cohort study
  publication-title: Schizophr. Res.
  doi: 10.1016/j.schres.2010.02.1061
– volume: 4
  start-page: 263
  year: 2017
  ident: ref_3
  article-title: Premature death in schizophrenia: Bridging the gap
  publication-title: Lancet Psychiatry
  doi: 10.1016/S2215-0366(17)30079-2
– volume: 48
  start-page: 492
  year: 2013
  ident: ref_36
  article-title: The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size
  publication-title: Exp. Gerontol.
  doi: 10.1016/j.exger.2013.02.012
– volume: 11
  start-page: 11
  year: 2012
  ident: ref_6
  article-title: Body composition in patients with schizophrenia: Comparison with healthy controls
  publication-title: Ann. Gen. Psychiatry
  doi: 10.1186/1744-859X-11-11
– volume: 9
  start-page: 256
  year: 2015
  ident: ref_41
  article-title: The impacts of sarcopenia and obesity on physical performance in the elderly
  publication-title: Obes. Res. Clin. Pract.
  doi: 10.1016/j.orcp.2014.08.003
– volume: 86
  start-page: 269
  year: 2006
  ident: ref_13
  article-title: Increased caffeine and nicotine consumption in community-dwelling patients with schizophrenia
  publication-title: Schizophr. Res.
  doi: 10.1016/j.schres.2006.05.013
– volume: 5
  start-page: 137
  year: 2014
  ident: ref_2
  article-title: Increased mortality in schizophrenia due to cardiovascular disease—A non-systematic review of epidemiology, possible causes, and interventions
  publication-title: Front. Psychiatry
  doi: 10.3389/fpsyt.2014.00137
– volume: 37
  start-page: 551
  year: 2018
  ident: ref_45
  article-title: Sufficient levels of 25-hydroxyvitamin D and protein intake required to increase muscle mass in sarcopenic older adults—The PROVIDE study
  publication-title: Clin. Nutr.
  doi: 10.1016/j.clnu.2017.01.005
– ident: ref_23
  doi: 10.20944/preprints201706.0081.v1
– ident: ref_1
– volume: 264
  start-page: 3
  year: 2014
  ident: ref_12
  article-title: Physical comorbidity and its relevance on mortality in schizophrenia: A naturalistic 12-year follow-up in general hospital admissions
  publication-title: Eur. Arch. Psychiatry Clin. Neurosci.
  doi: 10.1007/s00406-013-0436-x
– volume: 48
  start-page: 16
  year: 2019
  ident: ref_14
  article-title: Sarcopenia: Revised European consensus on definition and diagnosis
  publication-title: Age Ageing
  doi: 10.1093/ageing/afy169
– volume: 196
  start-page: 243
  year: 2018
  ident: ref_46
  article-title: Protein Energy Wasting and Sarcopenia in Dialysis Patients
  publication-title: Contrib. Nephrol.
  doi: 10.1159/000485729
– volume: 21
  start-page: 65
  year: 1993
  ident: ref_39
  article-title: Changes in skeletal muscle with aging: Effects of exercise training
  publication-title: Exerc. Sport Sci. Rev.
  doi: 10.1249/00003677-199301000-00003
– volume: 126
  start-page: 103
  year: 2011
  ident: ref_11
  article-title: Low cardiorespiratory fitness and physical functional capacity in obese patients with schizophrenia
  publication-title: Schizophr. Res.
  doi: 10.1016/j.schres.2010.10.025
– volume: 132
  start-page: 97
  year: 2015
  ident: ref_10
  article-title: Weight gain and obesity in schizophrenia: Epidemiology, pathobiology, and management
  publication-title: Acta Psychiatr. Scand.
  doi: 10.1111/acps.12445
– volume: 18
  start-page: 165
  year: 2019
  ident: ref_33
  article-title: Cognition and disability in schizophrenia: Cognition-related skills deficits and decision-making challenges add to morbidity
  publication-title: World Psychiatry
  doi: 10.1002/wps.20647
– volume: 17
  start-page: 612
  year: 2013
  ident: ref_20
  article-title: Designing pharmaceutical trials for sarcopenia in frail older adults: EU/US Task Force recommendations
  publication-title: J. Nutr. Health Aging
  doi: 10.1007/s12603-013-0362-7
– volume: 2
  start-page: 452
  year: 2015
  ident: ref_7
  article-title: Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses
  publication-title: Lancet Psychiatry
  doi: 10.1016/S2215-0366(15)00115-7
– volume: 33
  start-page: 737
  year: 2014
  ident: ref_32
  article-title: Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: From sarcopenic obesity to cachexia
  publication-title: Clin. Nutr.
  doi: 10.1016/j.clnu.2014.03.007
– volume: 40
  start-page: 603
  year: 2018
  ident: ref_25
  article-title: Human body water composition measurement: Methods and clinical application
  publication-title: Zhongguo Yi Xue Ke Xue Yuan Xue Bao
– volume: 13
  start-page: 271
  year: 2010
  ident: ref_15
  article-title: Functional consequences of sarcopenia and dynapenia in the elderly
  publication-title: Curr. Opin. Clin. Nutr. Metab. Care
  doi: 10.1097/MCO.0b013e328337819e
– volume: 3
  start-page: 194
  year: 2018
  ident: ref_31
  article-title: Prevalence and factors associated with sarcopenia and dynapenia in elderly people
  publication-title: J. Frailty Sarcopenia Falls
  doi: 10.22540/JFSF-03-194
– volume: 5
  start-page: e008720
  year: 2015
  ident: ref_17
  article-title: High prevalence of underweight and undernutrition in Japanese inpatients with schizophrenia: A nationwide survey
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2015-008720
– volume: 3
  start-page: 260
  year: 2012
  ident: ref_37
  article-title: Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review
  publication-title: Front. Physiol.
  doi: 10.3389/fphys.2012.00260
– volume: 8
  start-page: 755705
  year: 2021
  ident: ref_16
  article-title: Association between sarcopenia and depressive symptoms in Chinese older adults: Evidence from the China health and retirement longitudinal study
  publication-title: Front. Med.
  doi: 10.3389/fmed.2021.755705
– volume: 31
  start-page: 60
  year: 2021
  ident: ref_27
  article-title: The prevalence of sarcopenia in patients with schizophrenia
  publication-title: Psychiatry Clin. Psychopharmacol.
  doi: 10.5152/pcp.2021.20175
– volume: 11
  start-page: 177
  year: 2014
  ident: ref_38
  article-title: Clinical definition of sarcopenia
  publication-title: Clin Cases Miner Bone Metab.
– volume: 12
  start-page: 30
  year: 2021
  ident: ref_40
  article-title: Sarcopenia: Prevalence, associated factors, and the risk of mortality and disability in Japanese older adults
  publication-title: J. Cachexia Sarcopenia Muscle
  doi: 10.1002/jcsm.12651
– volume: 1
  start-page: 112
  year: 2014
  ident: ref_5
  article-title: Physical performance and disability in schizophrenia
  publication-title: Schizophr. Res. Cogn.
  doi: 10.1016/j.scog.2014.06.002
– volume: 20
  start-page: 100364
  year: 2021
  ident: ref_34
  article-title: Real world sedentary behavior and activity levels in patients with schizophrenia and controls: An ecological momentary assessment study
  publication-title: Ment. Health Phys. Act.
  doi: 10.1016/j.mhpa.2020.100364
– volume: 16
  start-page: 308
  year: 2017
  ident: ref_9
  article-title: Sedentary behavior and physical activity levels in people with schizophrenia, bipolar disorder and major depressive disorder: A global systematic review and meta-analysis
  publication-title: World Psychiatry
  doi: 10.1002/wps.20458
– volume: 8
  start-page: 115
  year: 2022
  ident: ref_48
  article-title: Physical Health Impairment and Exercise as Medicine in Severe Mental Disorders: A Narrative Review
  publication-title: Sports Med. Open
  doi: 10.1186/s40798-022-00490-3
– volume: 2
  start-page: 533
  year: 1976
  ident: ref_26
  article-title: Total body water content in normal and grossly obese women
  publication-title: Med. J. Aust.
  doi: 10.5694/j.1326-5377.1976.tb128209.x
– ident: ref_28
  doi: 10.3390/healthcare10101905
– volume: 129
  start-page: 122
  year: 2011
  ident: ref_8
  article-title: Lack of physical activity during leisure time contributes to an impaired health related quality of life in patients with schizophrenia
  publication-title: Schizophr. Res.
  doi: 10.1016/j.schres.2011.03.018
– ident: ref_18
– volume: 11
  start-page: 525231
  year: 2020
  ident: ref_29
  article-title: Grip Strength, Neurocognition, and social functioning in people WithType-2 diabetes mellitus, major depressive disorder, bipolar disorder, and schizophrenia
  publication-title: Front. Psychol.
  doi: 10.3389/fpsyg.2020.525231
– volume: 82
  start-page: 415
  year: 2020
  ident: ref_30
  article-title: Dynapenia and physical performance in community-dwelling elderly people in Japan
  publication-title: Nagoya J. Med. Sci.
– volume: 69
  start-page: 70
  year: 2022
  ident: ref_49
  article-title: Usefulness of 2D Video Analysis for Evaluation of Shoulder Range of Motion during Upper Limb Exercise in Patients with Psychiatric Disorders
  publication-title: J. Med. Investig.
  doi: 10.2152/jmi.69.70
– volume: 10
  start-page: 19129
  year: 2020
  ident: ref_35
  article-title: Prevalence and risk factors of sarcopenia in community-dwelling older adults visiting regional medical institutions from the Kadoma sarcopenia Study
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-020-76185-0
– volume: 14
  start-page: 542
  year: 2013
  ident: ref_44
  article-title: Evidence-based recommendations for optimal dietary protein intake in older people: A position paper from the PROT-AGE Study Group
  publication-title: J. Am. Med. Dir. Assoc.
  doi: 10.1016/j.jamda.2013.05.021
– volume: 2022
  start-page: 1381542
  year: 2022
  ident: ref_24
  article-title: Investigating body mass index and body composition in patients with schizophrenia: A case-control study
  publication-title: Schizophr. Res. Treat.
– ident: ref_19
– volume: 21
  start-page: 300
  year: 2020
  ident: ref_21
  article-title: Asian Working Group for Sarcopenia: 2019 Consensus update on sarcopenia diagnosis and treatment
  publication-title: J. Am. Med. Dir. Assoc.
  doi: 10.1016/j.jamda.2019.12.012
– volume: 85
  start-page: 1505
  year: 2016
  ident: ref_22
  article-title: Muscle analysis using pQCT, DXA and MRI
  publication-title: Eur. J. Radiol.
  doi: 10.1016/j.ejrad.2016.03.001
– volume: 10
  start-page: 322
  year: 2019
  ident: ref_42
  article-title: Importance of physical evaluation using skeletal muscle mass index and body fat percentage to prevent sarcopenia in elderly Japanese diabetes patients
  publication-title: J. Diabetes Investig.
  doi: 10.1111/jdi.12908
– volume: 8
  start-page: 15
  year: 2009
  ident: ref_4
  article-title: Metabolic syndrome in people with schizophrenia: A review
  publication-title: World Psychiatry
  doi: 10.1002/j.2051-5545.2009.tb00199.x
– volume: 195
  start-page: 67
  year: 2018
  ident: ref_47
  article-title: Prevalence of underweight in patients with schizophrenia: A meta-analysis
  publication-title: Schizophr. Res.
  doi: 10.1016/j.schres.2017.10.017
SSID ssj0000913835
Score 2.22619
Snippet Sedentary behavior in patients with schizophrenia causes muscle weakness, is associated with a higher risk of metabolic syndrome, and contributes to mortality...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 684
SubjectTerms Activities of daily living
Age
Analysis
Antipsychotics
Body composition
Disease
Exercise
Frailty
Health aspects
Hospitals
Lifestyles
Medical research
Medicine, Experimental
Metabolic syndrome
Muscle strength
Muscle weakness
Musculoskeletal system
Nutritional status
Obesity
Patients
Physical fitness
Pneumonia
Psychiatric patients
Psychotropic drugs
Quality of life
Sarcopenia
Schizophrenia
Sedentary behavior
Womens health
Working groups
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swED_68TIoZd9z1w0NCnsYIo5lOXJhjCxLKIOGsHbQNyPLMg10dtqm0P73vZNsL96gbwGdjcid7n4n3_0O4KgMTTrSI8utKCSP7TDlykjJdT4aKVR4VDg6htN5cvI7_nkhL7Zg3vbCUFll6xOdoy5qQ3fkg4imyCO4joffVtecpkbR19V2hIZuRisUXx3F2DbsoktWaPe736fzxa_u1oVYMBFz-O4Zgfn-4LIrs8JAKMNExb0I9a-f3ghU_SLKjag0ew77DZxkY6__F7Blq5ew5-_imG8xegXX03v9xw2CYDM_Xoe1WrEFo5tY9uOh0iuquxucoeXX7idbVmzhaVdvvdTZZoXeMRuzxfKqXrMJRkI-8TXvjAoTH17D-Wx6PjnhzagFbmQcrTnGr7wsFGZXkS6tVGEukiRWWhqESyYq4zLNEXtYG5ZaCEFZFXonTPXCQiGiEG9gp6or-w5YikLCYMwzOaU2WieFztVQGmEQqeUigGH772amoSGnaRhXGaYjpJHsf40E8KV7ZuVJOJ6U_kxKy-iE4puNbhoNcH_EdZWNibAnxsQtDOCwJ4kny_SXW7Vnzcm-zf7aYQCfumV6kqrVKlvfOZkkTBEJ4l7eeivp9i2SlNpy0gBUz346AeL77q9Uy0vH--0-xUgpD57e13t4FiESc3338hB21jd39gMip3X-sTkOjzXrGwE
  priority: 102
  providerName: ProQuest
Title Examining Factors Associated with Dynapenia/Sarcopenia in Patients with Schizophrenia: A Pilot Case-Control Study
URI https://www.ncbi.nlm.nih.gov/pubmed/36900689
https://www.proquest.com/docview/2785187541
https://www.proquest.com/docview/2786098934
https://pubmed.ncbi.nlm.nih.gov/PMC10000555
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3ra9swED_6-DIYo3t77YIGg30YWm3LsuXBGGmWUAYtYW2h34wsyzSQOX2k0Pz3u7NsE3ft2DeDzrbwnXS_n3wPgI-lb9JEJ5ZbUUge2SDlykjJdZ4kChUeFnU5hqPj-PAs-nkuzzegbXfUfMCbB6kd9ZM6u55_ubtafccF_40YJ1L2_YsuUgp9mfRjFW3CNnqmmMjYUQP36505DZCQUVQjZYDy1Behy6N55DE9X3V_x15zWf1wyjX_NNmBZw2wZENnCc9hw1Yv4Kk7lWMu2eglXI3v9O-6JQSbuEY7rNWPLRidybIfq0pfUgTe_gmugUV9yWYVm7oCrDdO6mQ9Vu8rG7LpbL5YshH6RD5y0e-MQhRXr-B0Mj4dHfKm6QI3MgqXHD1ZXhYKeVaoSyuVn4s4jpSWBoGTCcuoTHNEIdb6pRZCEL_CfQpJn18oxBbiNWxVi8q-BZaikDDo_UxOJEfruNC5CqQRBjFbLjwI2q-bmaYgOfXFmGdITEgj2d8a8eBzd8-lK8fxT-lPpLSMrAefbHSTcoDzo6pX2ZBK90RI4XwP9nqSuMZMf7hVe9aaaBYmiFaR7kWBBx-6YbqT4tYqu7itZWI_RUyIc3njrKSbt4hTStBJPVA9--kEqPJ3f6SaXdQVwOufMlLKd__x4l14EiIwq9Pw5R5sLa9v7XsEUst8AJtqFAxg-2B8PP01qNfKH4iTH8s
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3di9QwEB_O80FBxG-rp0ZQfJCybdN0U0Fk2btlz_vg4Fa4t5CmKbdwtnvuHrp_lP-jM01btwr3dm-FTErIzOQ3k8wHwLsiMOlQD61veS782IapL40Qvs6GQ4kMj_K6HMPRcTL9Fn89E2db8LvNhaGwyvZMrA_qvDJ0Rz6IqIs8Gtdx-GVx6VPXKHpdbVtoOLE4sOuf6LItP-_vIn_fR9Fkbzae-k1XAd-IOFr5eFRnRS7RkYh0YYUMMp4ksdTCoGVgoiIu0gxh1tqg0JxzciBQEdGrCXKJ4Mnxt7fgdsx5Qkokx2F3pUMlNtGgcak5nKfB4LyL4UKUFUEi4x78_QsCGyjYj9DcgLzJA7jf2Kps5ITrIWzZ8hHccxd9zOUvPYbLvV_6e91lgk1c7x7WstzmjK552e661AsK6huc4v5V9Sebl-zE1XRdOqrTzfC_T2zETuYX1YqNEWb9sQuoZxT1uH4Cs5vY8aewXValfQ4sRSJuEFBNRn6T1kmuMxkKww2agRn3IGx3V5mmxjm12rhQ6OsQR9T_HPHgYzdn4Sp8XEv9gZimSP3xz0Y3WQy4PiqkpUZUDShGrzDwYKdHiWpr-sMt21VzbCzVXyH34G03TDMpFK601VVNkwQpmpm4lmdOSrp1o0xSzk_qgezJT0dAxcT7I-X8vC4qXr_zCCFeXL-uN3BnOjs6VIf7xwcv4W6EJl-d4C92YHv148q-QhNtlb2uFYOBumFF_ANb7E5M
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9RAEB9qBRGK-G1qqysoPki4JJtNNoLIcdejtVoOWqFvYbPZ0IM2ufau6P1p_nfOZJP0otC3vgV2Epad781vZgDeF55OYhUb1_BcuKHxE1dqIVyVxbFEhgd53Y7hx1G0_zP8dipON-BPWwtDsMrWJtaGOq803ZEPApoij8F16A-KBhYxHU--zi9dmiBFf1rbcRpWRA7N6hemb4svB2Pk9YcgmOydjPbdZsKAq0UYLF0021mRS0wqAlUYIb2MR1EoldAYJeigCIskQ5drjFcozjklE6iUmOF4uURHyvGz9-B-zOOYlEuO_O56h9ptYnBjy3Q4T7zBWYfnQo8rvEiGPVf4r0NY84h9tOaa-5s8hkdN3MqGVtCewIYpn8KWvfRjtpbpGVzu_VYX9cQJNrFzfFjLfpMzuvJl41Wp5gTwGxzj-VX1I5uVbGr7uy4s1fE6FPAzG7Lp7LxashG6XHdkwfWMEJCr53ByFyf-AjbLqjSvgCVIxDU6V51RDqVUlKtM-kJzjSFhxh3w29NNddPvnMZunKeY9xBH0v854sCn7p257fZxK_VHYlpKpgC_rFVT0YD7o6Za6ZA6A4WYIXoO7PQoUYV1f7lle9qYkEV6I_AOvOuW6U2CxZWmuq5pIi_BkBP38tJKSbdvHiVU_5M4IHvy0xFQY_H-Sjk7qxuM1_98hBDbt-_rLTxAFUy_HxwdvoaHAUZ_da2_2IHN5dW12cVobZm9qfWCQXrHevgX3sNSgg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Examining+Factors+Associated+with+Dynapenia%2FSarcopenia+in+Patients+with+Schizophrenia%3A+A+Pilot+Case-Control+Study&rft.jtitle=Healthcare+%28Basel%29&rft.au=Tanioka%2C+Ryuichi&rft.au=Osaka%2C+Kyoko&rft.au=Ito%2C+Hirokazu&rft.au=Zhao%2C+Yueren&rft.date=2023-02-25&rft.issn=2227-9032&rft.eissn=2227-9032&rft.volume=11&rft.issue=5&rft_id=info:doi/10.3390%2Fhealthcare11050684&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2227-9032&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2227-9032&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2227-9032&client=summon